Regents of the University of California’s Centessa Pharmaceuticals CNTA Stock Holding History

Regents of the University of California’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-81,884	Closed	-$1.18M	–	7
2025 Q1	$1.18M	Buy	+81,884	New	+$1.34M	0.25%	6

Other funds holding CNTA

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

IVLAV

Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Regents of the University of California's CNTA Position: Q2 2025 in Review

Regents of the University of California sold out of Centessa Pharmaceuticals (CNTA) in Q2 2025, closing a stake of 81,884 shares — an estimated $1.18M sold.

Regents of the University of California first reported a position in CNTA in Q1 2025 and held it in 1 quarter. The position peaked at $1.18M in Q1 2025. 117 funds tracked by Wall St. Rank hold CNTA as of Q2 2025.

Regents of the University of California reported no remaining Centessa Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Regents of the University of California sold 81,884 Centessa Pharmaceuticals shares in Q2 2025, an estimated $1.18M.
Regents of the University of California first reported a position in Centessa Pharmaceuticals in Q1 2025 and held it in 1 quarter.
Regents of the University of California's Centessa Pharmaceuticals position peaked at $1.18M in Q1 2025.
117 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2025.

Based on Regents of the University of California's 13F filing for Q2 2025, filed 12 Aug 2025.